WHO advises against using plasma from COVID-19 survivors to treat patients battling the virus – Community News

WHO advises against using plasma from COVID-19 survivors to treat patients battling the virus

World Health Organization experts on Tuesday advised against using blood plasma from people who have recovered from COVID-19 as a treatment for patients with the disease, saying there is no evidence that the costly, time-consuming transfusions are effective in preventing serious illness or disease. dead.

RELATED: WHO: Children aged 5-14 are responsible for Europe’s highest COVID-19 rates

The guideline against the use of convalescent plasma, a component of blood rich in antibodies, was published in the British Medical Journal based on results from 16 studies involving more than 16,000 patients with varying degrees of coronavirus infection, the WHO said.

“Despite initial promise, current evidence shows it does not improve survival or reduce the need for mechanical ventilation, and it is expensive and time-consuming to administer,” the UN health organization said in announcing its recommendation. an international group of experts. on guideline development.

RELATED: Omicron variant may be less dangerous than delta, US health officials say

As such, the WHO strongly recommends against the use of convalescent plasma in patients with non-serious disease, and a recommendation against its use in patients with severe and critical illness, except in the context of a randomized controlled trial, WHO said.

The group of experts said in an 81-page study that there was “no apparent benefit to critical outcomes” such as the need for mechanical ventilation — ventilators — or death of COVID-19 patients.

The WHO previously weighed in on other COVID-19 treatments, such as recommending some steroids for patients with severe or critical cases, and advising against the use of the antiparasite medication ivermectin and the malaria drug hydroxychloroquine.